Despite short-term blip, Sun Pharma remains favourite among investors
Around six weeks ago, Sun Pharmaceutical Industries, India’s largest drugmaker, suffered a setback, which led to a selloff in the share. Photograph: Francis Mascarenhas/Reuters The US District Court of ...
